Titre : Os spongieux

Os spongieux : Questions médicales fréquentes

Termes MeSH sélectionnés :

Unsupervised Machine Learning
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Os spongieux : Questions médicales les plus fréquentes", "headline": "Os spongieux : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Os spongieux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-08", "dateModified": "2025-05-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Os spongieux" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Os et tissu osseux", "url": "https://questionsmedicales.fr/mesh/D001842", "about": { "@type": "MedicalCondition", "name": "Os et tissu osseux", "code": { "@type": "MedicalCode", "code": "D001842", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A10.165.265" } } }, "about": { "@type": "MedicalCondition", "name": "Os spongieux", "alternateName": "Cancellous Bone", "code": { "@type": "MedicalCode", "code": "D000071556", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mohammad Salem", "url": "https://questionsmedicales.fr/author/Mohammad%20Salem", "affiliation": { "@type": "Organization", "name": "Department of Mechanical Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada." } }, { "@type": "Person", "name": "Lindsey Westover", "url": "https://questionsmedicales.fr/author/Lindsey%20Westover", "affiliation": { "@type": "Organization", "name": "Department of Mechanical Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada." } }, { "@type": "Person", "name": "Samer Adeeb", "url": "https://questionsmedicales.fr/author/Samer%20Adeeb", "affiliation": { "@type": "Organization", "name": "Department of Civil and Environmental Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada." } }, { "@type": "Person", "name": "Kajsa Duke", "url": "https://questionsmedicales.fr/author/Kajsa%20Duke", "affiliation": { "@type": "Organization", "name": "Department of Mechanical Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada." } }, { "@type": "Person", "name": "Bin Wu", "url": "https://questionsmedicales.fr/author/Bin%20Wu", "affiliation": { "@type": "Organization", "name": "College of Mechanical and Electronic Engineering, Nanjing Forestry University, Nanjing 210037, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Profiling Physical Fitness of Physical Education Majors Using Unsupervised Machine Learning.", "datePublished": "2022-12-22", "url": "https://questionsmedicales.fr/article/36612474", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20010146" } }, { "@type": "ScholarlyArticle", "name": "Communicating exploratory unsupervised machine learning analysis in age clustering for paediatric disease.", "datePublished": "2024-07-29", "url": "https://questionsmedicales.fr/article/39074912", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjhci-2023-100963" } }, { "@type": "ScholarlyArticle", "name": "Cell deformability heterogeneity recognition by unsupervised machine learning from in-flow motion parameters.", "datePublished": "2022-12-06", "url": "https://questionsmedicales.fr/article/36398860", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1039/d2lc00902a" } }, { "@type": "ScholarlyArticle", "name": "Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury.", "datePublished": "2022-11-08", "url": "https://questionsmedicales.fr/article/36302734", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jgh.16038" } }, { "@type": "ScholarlyArticle", "name": "Uncovering psychiatric phenotypes using unsupervised machine learning: A data-driven symptoms approach.", "datePublished": "2023-02-21", "url": "https://questionsmedicales.fr/article/36804948", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1192/j.eurpsy.2023.13" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Tissus", "item": "https://questionsmedicales.fr/mesh/D014024" }, { "@type": "ListItem", "position": 3, "name": "Tissu conjonctif", "item": "https://questionsmedicales.fr/mesh/D003238" }, { "@type": "ListItem", "position": 4, "name": "Os et tissu osseux", "item": "https://questionsmedicales.fr/mesh/D001842" }, { "@type": "ListItem", "position": 5, "name": "Os spongieux", "item": "https://questionsmedicales.fr/mesh/D000071556" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Os spongieux - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Os spongieux", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Os spongieux", "description": "Comment diagnostiquer une fragilité osseuse ?\nQuels tests sanguins sont utiles ?\nQuels signes indiquent une maladie osseuse ?\nQuand faire une densitométrie osseuse ?\nQuels symptômes nécessitent une évaluation osseuse ?", "url": "https://questionsmedicales.fr/mesh/D000071556?mesh_terms=Unsupervised+Machine+Learning&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Os spongieux", "description": "Quels sont les symptômes d'une fracture osseuse ?\nComment reconnaître l'ostéoporose ?\nQuels signes de faiblesse osseuse ?\nY a-t-il des symptômes associés à l'ostéomalacie ?\nQuels symptômes d'une infection osseuse ?", "url": "https://questionsmedicales.fr/mesh/D000071556?mesh_terms=Unsupervised+Machine+Learning&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Os spongieux", "description": "Comment prévenir l'ostéoporose ?\nQuel rôle de l'exercice pour les os ?\nPourquoi éviter le tabac pour les os ?\nComment la vitamine D aide-t-elle les os ?\nQuels aliments sont bons pour les os ?", "url": "https://questionsmedicales.fr/mesh/D000071556?mesh_terms=Unsupervised+Machine+Learning&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Os spongieux", "description": "Quels traitements pour l'ostéoporose ?\nComment traiter une fracture osseuse ?\nQuels médicaments renforcent les os ?\nQuel rôle de la physiothérapie ?\nComment la nutrition aide-t-elle les os ?", "url": "https://questionsmedicales.fr/mesh/D000071556?mesh_terms=Unsupervised+Machine+Learning&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Os spongieux", "description": "Quelles complications des fractures ?\nQuels risques d'ostéoporose non traitée ?\nComment l'ostéomalacie complique-t-elle la santé ?\nQuelles complications des infections osseuses ?\nQuels effets des médicaments sur les os ?", "url": "https://questionsmedicales.fr/mesh/D000071556?mesh_terms=Unsupervised+Machine+Learning&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Os spongieux", "description": "Quels facteurs augmentent le risque d'ostéoporose ?\nComment l'alimentation influence-t-elle les os ?\nQuel impact du mode de vie sur la santé osseuse ?\nLes antécédents familiaux influencent-ils les os ?\nQuel rôle du sexe dans la santé osseuse ?", "url": "https://questionsmedicales.fr/mesh/D000071556?mesh_terms=Unsupervised+Machine+Learning&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une fragilité osseuse ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des examens d'imagerie comme la radiographie ou l'IRM." } }, { "@type": "Question", "name": "Quels tests sanguins sont utiles ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de calcium, vitamine D et marqueurs de remodelage osseux aident au diagnostic." } }, { "@type": "Question", "name": "Quels signes indiquent une maladie osseuse ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Douleurs osseuses, fractures fréquentes et perte de hauteur peuvent indiquer une maladie." } }, { "@type": "Question", "name": "Quand faire une densitométrie osseuse ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Elle est recommandée pour les personnes à risque d'ostéoporose, généralement après 50 ans." } }, { "@type": "Question", "name": "Quels symptômes nécessitent une évaluation osseuse ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs persistantes ou des fractures sans traumatisme doivent être évaluées." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une fracture osseuse ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Douleur intense, gonflement et incapacité à utiliser le membre affecté sont fréquents." } }, { "@type": "Question", "name": "Comment reconnaître l'ostéoporose ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "L'ostéoporose est souvent asymptomatique jusqu'à une fracture, mais peut causer des douleurs." } }, { "@type": "Question", "name": "Quels signes de faiblesse osseuse ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Perte de hauteur, courbure de la colonne vertébrale et fractures fréquentes sont des signes." } }, { "@type": "Question", "name": "Y a-t-il des symptômes associés à l'ostéomalacie ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Douleurs osseuses, faiblesse musculaire et déformations osseuses peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes d'une infection osseuse ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleur localisée et rougeur autour de l'os peuvent indiquer une infection." } }, { "@type": "Question", "name": "Comment prévenir l'ostéoporose ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée, l'exercice régulier et l'arrêt du tabac sont essentiels." } }, { "@type": "Question", "name": "Quel rôle de l'exercice pour les os ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice renforce les os et améliore l'équilibre, réduisant le risque de chutes." } }, { "@type": "Question", "name": "Pourquoi éviter le tabac pour les os ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme réduit la densité osseuse et augmente le risque de fractures." } }, { "@type": "Question", "name": "Comment la vitamine D aide-t-elle les os ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "La vitamine D favorise l'absorption du calcium, essentielle pour la santé osseuse." } }, { "@type": "Question", "name": "Quels aliments sont bons pour les os ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les produits laitiers, les légumes verts et les poissons gras sont bénéfiques pour les os." } }, { "@type": "Question", "name": "Quels traitements pour l'ostéoporose ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les bisphosphonates, la vitamine D et l'exercice sont des traitements courants." } }, { "@type": "Question", "name": "Comment traiter une fracture osseuse ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure immobilisation, chirurgie ou réhabilitation selon la gravité." } }, { "@type": "Question", "name": "Quels médicaments renforcent les os ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les médicaments comme le raloxifène et les bisphosphonates aident à renforcer les os." } }, { "@type": "Question", "name": "Quel rôle de la physiothérapie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La physiothérapie aide à renforcer les muscles et améliorer la mobilité après une fracture." } }, { "@type": "Question", "name": "Comment la nutrition aide-t-elle les os ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en calcium et vitamine D est essentielle pour la santé osseuse." } }, { "@type": "Question", "name": "Quelles complications des fractures ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'infection, la non-union osseuse et la douleur chronique." } }, { "@type": "Question", "name": "Quels risques d'ostéoporose non traitée ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "L'ostéoporose non traitée augmente le risque de fractures graves et de déformations." } }, { "@type": "Question", "name": "Comment l'ostéomalacie complique-t-elle la santé ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des déformations osseuses et des douleurs chroniques si non traitée." } }, { "@type": "Question", "name": "Quelles complications des infections osseuses ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les infections osseuses peuvent causer des douleurs persistantes et des dommages osseux." } }, { "@type": "Question", "name": "Quels effets des médicaments sur les os ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent entraîner une perte osseuse ou des effets secondaires indésirables." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'ostéoporose ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge, le sexe féminin, l'hérédité et un mode de vie sédentaire augmentent le risque." } }, { "@type": "Question", "name": "Comment l'alimentation influence-t-elle les os ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation pauvre en calcium et vitamine D augmente le risque de maladies osseuses." } }, { "@type": "Question", "name": "Quel impact du mode de vie sur la santé osseuse ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sédentaire et le tabagisme nuisent à la santé osseuse." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils les os ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'ostéoporose augmentent le risque personnel." } }, { "@type": "Question", "name": "Quel rôle du sexe dans la santé osseuse ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les femmes, surtout après la ménopause, sont plus à risque d'ostéoporose que les hommes." } } ] } ] }

Sources (10000 au total)

Communicating exploratory unsupervised machine learning analysis in age clustering for paediatric disease.

Despite the increasing availability of electronic healthcare record (EHR) data and wide availability of plug-and-play machine learning (ML) Application Programming Interfaces, the adoption of data-dri... Observational EHR data from a tertiary paediatric hospital, containing 61 522 unique patients and 3315 unique ICD-10 diagnosis codes was used, after preprocessing. K-means clustering was applied to id... Four age clusters of diseases were identified, broadly aligning to ages between: 0 and 1; 1 and 5; 5 and 13; 13 and 18. Diagnoses, within the clusters, aligned to existing knowledge regarding the prop... Unsupervised ML applied to EHR data identifies clinically relevant age distributions of diagnoses which can augment existing decision making. However, biases within healthcare datasets dramatically im...

Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury.

Immune-related liver injury (liver-irAE) is a clinical problem with a potentially poor prognosis.... We retrospectively collected clinical data from patients treated with immune checkpoint inhibitors between September 2014 and December 2021 at the Nagoya University Hospital. Using an unsupervised mac... This study included a total of 702 patients. Among them, 492 (70.1%) patients were male, and the mean age was 66.6 years. During the mean follow-up period of 423 days, severe liver-irAEs (Common Termi... The combined assessment of multiple markers and body temperature may help stratify high-risk groups for developing liver-irAE....

Uncovering psychiatric phenotypes using unsupervised machine learning: A data-driven symptoms approach.

Current categorical classification systems of psychiatric diagnoses lead to heterogeneity of symptoms within disorders and common co-occurrence of disorders. We investigated the heterogeneous and over... We assessed a total of 43 symptoms in a discovery sample of 6,602 participants of the population-based Rotterdam Study between 2009 and 2013, and in a replication sample of 3,005 participants between ... First, clustering analyses of the questionnaire items suggested a three-cluster solution representing clusters of "mixed" symptoms, "depressed affect and nervousness", and "troubled sleep and interper... We identified three clusters of psychiatric symptoms that most commonly co-occur in a population-based sample. These symptoms clustered stable over samples, but across the topics of depression, anxiet...

An unsupervised machine learning approach using passive movement data to understand depression and schizophrenia.

Schizophrenia and Major Depressive Disorder (MDD) are highly burdensome mental disorders, with significant cost to both individuals and society. Despite these disorders representing distinct clinical ... The present analyses utilized raw minute-level actigraphy data from three diagnostic groups: individuals with schizophrenia (N = 23), individuals with depression (N = 22), and controls (N = 32), respe... We find distinct actigraphic phenotypes, which differ between diagnostic groups, suggesting that unsupervised clustering of naturalistic data aligns with existing diagnostic constructs. Further, we fo... However, diagnostic group differences only consider biobehavioral trends captured by raw actigraphy information.... Passively-collected movement information combined with unsupervised deep learning algorithms shows promise in identifying naturalistic phenotypes in individuals with mental health disorders, specifica...

Unsupervised machine learning model to predict cognitive impairment in subcortical ischemic vascular disease.

It is challenging to predict which patients who meet criteria for subcortical ischemic vascular disease (SIVD) will ultimately progress to subcortical vascular cognitive impairment (SVCI).... We collected clinical information, neuropsychological assessments, T1 imaging, diffusion tensor imaging, and resting-state functional magnetic resonance imaging from 83 patients with SVCI and 53 age-m... The accuracy, sensitivity, and specificity of the unsupervised machine learning model were 86.03%, 79.52%, and 96.23% and 80.52%, 71.11%, and 93.75% for internal and external cohort, respectively.... We developed an accurate and accessible clinical tool which requires only data from routine imaging to predict patients at risk of progressing from SIVD to SVCI.... Our unsupervised machine learning model provides an accurate and accessible clinical tool to predict patients at risk of progressing from subcortical ischemic vascular disease (SIVD) to subcortical va...

The unsupervised machine learning to analyze the use strategy of statins for ischaemic stroke patients with elevated transaminase.

Statins could elevate hepatic transaminase in ischemic stroke patients. There needed to be more evidence on which method stopped statins or adjusting the dose of statins was better for patients. And n... We collected ischaemic stroke patients with elevated hepatic transaminase when they take statins. The outcome was a recurrent stroke rate, transaminase value after stopping or adjusted, mortality, and... The patients stopping statins had a higher stroke recurrence and rate of FFO (mRS 0-2), a lower mean value of transaminase, and mortality. By difference unsupervised machine learning group, the km2 gr... For ischemic patients with elevated hepatic transaminase, stopping statins temporarily was a better choice of treatment strategy. These patients who were younger, male, with a lesser NIHSS score at ad...